NCT00758186已完成3 期
Endoscopic Stenting and Elective Surgery Versus Emergency Surgery for Left-sided Malignant Colonic Obstruction: A Prospective Randomized Trial.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- The primary endpoint was postoperative complication rates.
研究概览
简要总结
The objective of this randomized controlled trial was to evaluate the role colonic self-expanding metal stent (SEMS) placement as a bridge to surgery in patients with acute malignant left-sided colonic obstruction. The study was designed to test the hypothesis that SEMS placement could be effectively and safely used in this group of patients to relieve colonic obstruction thereby allowing safe recovery and medical stabilization before proceeding to elective surgery
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute intestinal obstruction secondary to left-sided colonic cancer
排除标准
- •Distal rectal cancers
- •Patients with signs of peritonitis suggestive of bowel perforation
结局指标
主要结局
The primary endpoint was postoperative complication rates.
时间窗: 30 days
次要结局
- Secondary outcomes evaluated included type of surgery performed, bowel preservation, presence of a stoma, postoperative bowel function, length of hospital stay, and hospitalization costs.(3 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Endoscopic Stenting for Chronic Abdominal PainChronic PancreatitisNCT00754676Leigh Powell2
已完成
4 期
Plantar Fasciitis, Operation or Conservative TreatmentPlantar FasciitisNCT02448316Bispebjerg Hospital30
终止
4 期
Iliac, Common and External (ICE) Artery Stent TrialVascular LesionsNCT01305174Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.660
已完成
不适用
Partially Covered and Uncovered Metal Stent for Malignant Distal Biliary StrictureMalignant Distal Biliary StrictureNCT02178618Ajou University School of Medicine
已完成
不适用
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary CancerPancreatic CarcinomaNCT01774019Boston Scientific Corporation284